MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Alfuzosin

Alfuzosin 2.5mg tablets

No stability information

Stability notes for Alfuzosin 2.5mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Alfuzosin 2.5mg tablets
Alfuzosin 2.5mg tablets (A A H Pharmaceuticals Ltd)
Alfuzosin 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Alfuzosin 2.5mg tablets (Medihealth (Northern) Ltd)
Alfuzosin 2.5mg tablets (Milpharm Ltd)
Alfuzosin 2.5mg tablets (Phoenix Healthcare Distribution Ltd)
Alfuzosin 2.5mg tablets (Sigma Pharmaceuticals Plc)
Alfuzosin 2.5mg tablets (Teva UK Ltd)
Alfuzosin 2.5mg tablets (Zentiva Pharma UK Ltd)

Alfuzosin 10mg modified-release tablets

Use with caution

Stability notes for Alfuzosin 10mg modified-release tablets

Protect from moisture. Protect from light. Manufacturer recommends storing in original container. No stability data in MCAs available. Anecdotal reports of use in MCAs for up to 7 days (low quality evidence).

Provenance

This recommendation is based on the products Xatral XL 10mg prolonged release tablets (Sanofi), Besavar XL 10mg tablets (Zentiva) and Vasran XL 10mg prolonged-release tablets (Ranbaxy UK Ltd a Sun Pharmaceutical Company).

Suppliers (6) of Alfuzosin 10mg modified-release tablets
Besavar XL 10mg tablets (Zentiva Pharma UK Ltd)
Fuzatal XL 10mg tablets (Teva UK Ltd)
Vasran XL 10mg tablets (Sun Pharma UK Ltd)
Xatral XL 10mg tablets (Sanofi)
Xatral XL 10mg tablets (Sigma Pharmaceuticals Plc)
Zochek 10mg modified-release tablets (Milpharm Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.